Effects of Gangliosides on the Activity of the Plasma Membrane Ca2+-ATPase
dc.contributor.author | Jiang, Lei | |
dc.contributor.author | Bechtel, Misty D. | |
dc.contributor.author | Bean, Jennifer L. | |
dc.contributor.author | Winefield, Robert D. | |
dc.contributor.author | Williams, Todd D. | |
dc.contributor.author | Zaidi, Asma | |
dc.contributor.author | Michaelis, Elias K. | |
dc.contributor.author | Michaelis, Mary Lou | |
dc.date.accessioned | 2017-02-01T20:36:32Z | |
dc.date.available | 2017-02-01T20:36:32Z | |
dc.date.issued | 2014-01-14 | |
dc.identifier.citation | Jiang, Lei, Misty D. Bechtel, Jennifer L. Bean, Robert Winefield, Todd D. Williams, Asma Zaidi, Elias K. Michaelis, and Mary L. Michaelis. "Effects of Gangliosides on the Activity of the Plasma Membrane Ca2 -ATPase." Biochimica Et Biophysica Acta (BBA) - Biomembranes 1838.5 (2014): 1255-265. | en_US |
dc.identifier.uri | http://hdl.handle.net/1808/22718 | |
dc.description.abstract | Control of intracellular calcium concentrations ([Ca2+]i) is essential for neuronal function, and the plasma membrane Ca2+-ATPase (PMCA) is crucial for the maintenance of low [Ca2+]i. We previously reported on loss of PMCA activity in brain synaptic membranes during aging. Gangliosides are known to modulate Ca2+ homeostasis and signal transduction in neurons. In the present study, we observed age-related changes in the ganglioside composition of synaptic plasma membranes. This led us to hypothesize that alterations in ganglioside species might contribute to the age-associated loss of PMCA activity. To probe the relationship between changes in endogenous ganglioside content or composition and PMCA activity in membranes of cortical neurons, we induced depletion of gangliosides by treating neurons with D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (D-PDMP). This caused a marked decrease in the activity of PMCA, which suggested a direct correlation between ganglioside content and PMCA activity. Neurons treated with neuraminidase exhibited an increase in GM1 content, a loss in poly-sialoganglioside content, and a decrease in PMCA activity that was greater than that produced by D-PDMP treatment. Thus, it appeared that poly-sialogangliosides had a stimulatory effect whereas mono-sialogangliosides had the opposite effect. Our observations add support to previous reports of PMCA regulation by gangliosides by demonstrating that manipulations of endogenous ganglioside content and species affect the activity of PMCA in neuronal membranes. Furthermore, our studies suggest that age-associated loss in PMCA activity may result in part from changes in the lipid environment of this Ca2+ transporter. | en_US |
dc.publisher | Elsevier | en_US |
dc.rights | This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License 3.0 (CC BY-NC-ND 3.0 US), which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. | en_US |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/ | |
dc.subject | Aging | en_US |
dc.subject | Gangliosides | en_US |
dc.subject | Plasma membrane Ca2+-ATPase | en_US |
dc.subject | Calcium | en_US |
dc.subject | Neuraminidase | en_US |
dc.subject | D(L)-threo-1-phenl-2-decanoylamino-3-morpholino-1-propanol (D-PDMP) | en_US |
dc.title | Effects of Gangliosides on the Activity of the Plasma Membrane Ca2+-ATPase | en_US |
dc.type | Article | en_US |
kusw.kuauthor | Winefield, Robert | |
kusw.kudepartment | Pharmacology & Toxicology | en_US |
kusw.oanotes | Per SHERPA/RoMEO 2/1/2017: Author's Pre-print: green tick author can archive pre-print (ie pre-refereeing) Author's Post-print: green tick author can archive post-print (ie final draft post-refereeing) Publisher's Version/PDF: cross author cannot archive publisher's version/PDF General Conditions: Authors pre-print on any website, including arXiv and RePEC Author's post-print on author's personal website immediately Author's post-print on open access repository after an embargo period of between 12 months and 48 months Permitted deposit due to Funding Body, Institutional and Governmental policy or mandate, may be required to comply with embargo periods of 12 months to 48 months Author's post-print may be used to update arXiv and RepEC Publisher's version/PDF cannot be used Must link to publisher version with DOI Author's post-print must be released with a Creative Commons Attribution Non-Commercial No Derivatives License | en_US |
dc.identifier.doi | 10.1016/j.bbamem.2014.01.003 | en_US |
dc.identifier.orcid | https://orcid.org/0000-0002-0944-5407 | |
kusw.oaversion | Scholarly/refereed, author accepted manuscript | en_US |
kusw.oapolicy | This item meets KU Open Access policy criteria. | en_US |
dc.rights.accessrights | openAccess |
Files in this item
This item appears in the following Collection(s)
-
Pharmacy Scholarly Works [286]
Except where otherwise noted, this item's license is described as: This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License 3.0 (CC BY-NC-ND 3.0 US), which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.